Stock Events

Stock Events

TransThera Sciences (Nanjing) 

HK$7.98
1
+HK$0.17+2.11% 06:13 Today

Statistics

Day High
8.06
Day Low
7.71
52W High
246
52W Low
7.53
Volume
702,417,000
Avg. Volume
-
Mkt Cap
3.25B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2023
2024
2025
0Revenue
-327.22MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases. The company provides Tinengotinib (TT-00420), a MTK inhibitor that is in clinical stage for the treatment of recurrent or refractory drug-resistant solid tumors. It also develops TT-00973, a kinase inhibitor for treating various cancers; TT-01488, a BTK inhibitor for the treatment of B-cell lymphoma; TT-01688, an oral S1P1 modulator for treating various inflammatory diseases; TT-00920, an oral PDE9 inhibitor used for treating central nervous system diseases; TT-01025, an oral irreversible VAP-1 inhibitor designed for the treatment of NASH; and TT-02332, a NLRP3 inhibitor for metabolic and inflammatory diseases. The company has a collaboration with Neurocrine Biosciences, Inc. to develop NLRP3 inhibitors for multiple disease. TransThera Sciences (Nanjing), Inc. was formerly known as Nanjing TransThera Biosciences Co. Ltd. and changed its name to TransThera Sciences (Nanjing), Inc. in July 2021. The company was incorporated in 2014 and is headquartered in Nanjing, China.
Show More
CEO
Yong Qian Wu
Employees
132
Country
China
ISIN
CNE100006T02
WKN
000A41B4G

Listings

HK
HK
2617.HK
F
DE
J8J.F

0 Comments

Share your thoughts

FAQs

What is TransThera Sciences (Nanjing) stock price today?▼
The current price of 2617.HK is HK$7.98 HKD — it has increased by +2.11% in the past 24 hours. Watch TransThera Sciences (Nanjing) stock price performance more closely on the chart.
What is TransThera Sciences (Nanjing) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange TransThera Sciences (Nanjing) stocks are traded under the ticker 2617.HK.
Is TransThera Sciences (Nanjing) stock price growing?▼
2617.HK stock has fallen by -9.53% compared to the previous week, the month change is a -26.49% fall, over the last year TransThera Sciences (Nanjing) has showed a -95.65% decrease.
What is TransThera Sciences (Nanjing) market cap?▼
Today TransThera Sciences (Nanjing) has the market capitalization of 3.25B
What is TransThera Sciences (Nanjing) revenue for the last year?▼
TransThera Sciences (Nanjing) revenue for the last year amounts to 0 HKD.
What is TransThera Sciences (Nanjing) net income for the last year?▼
2617.HK net income for the last year is -327.22M HKD.
How many employees does TransThera Sciences (Nanjing) have?▼
As of November 4, 2026, the company has 132 employees.
In which sector is TransThera Sciences (Nanjing) located?▼
TransThera Sciences (Nanjing) operates in the Health & Wellness sector.
When did TransThera Sciences (Nanjing) complete a stock split?▼
TransThera Sciences (Nanjing) has not had any recent stock splits.
Where is TransThera Sciences (Nanjing) headquartered?▼
TransThera Sciences (Nanjing) is headquartered in Nanjing, China.